Skip to main content

Cepheid Shares Jump Nearly 18 Percent After FDA Clearance

Shares in Cepheid rose 17.8 percent for the five-day trading period ended Tuesday, following last week’s clearance by the US Food and Drug Administration of the firm’s meningitis molecular diagnostic assay. The test is Cepheid’s third molecular diagnostic product cleared by the FDA for sale in the US.
 
Shares in Affymetrix also continued their rise this week following a jury’s verdict last week that Illumina had infringed several Affy patents and awarded Affy $16.7 million in damages (see BioCommerce Week 3/14/2007). In addition, Bruker BioSciences hit a 52-week high of $10.54 on Tuesday before closing at $10.28.
 
Caliper Life Sciences led the two decliners in the BCW Index, with a drop of 6.5 percent for the tracking period.
 
Overall, the Index gained 2.9 percent for the week, outpacing the Nasdaq, which rose 2.5 percent, and the Nasdaq Biotech Index, which rose 1.2 percent. The Dow Jones Industrial Average rose 1.8 percent for the period.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price (March 20, 2007)
Starting Price Jan. (March 13, 2007)
% change
Affymetrix
AFFX
28.89
26.62
8.53
Agilent
A
32.06
31.67
1.23
Applied Biosystems
ABI
29.73
28.55
4.13
Beckman
BEC
65.58
64.98
0.92
Becton Dickinson
BDX
75.12
73.48
2.23
Bio-Rad
BIO
70.45
67.67
4.11
Bruker
BRKR
10.28
9.47
8.55
Caliper
CALP
5.36
5.73
-6.46
Cepheid
CPHD
10.01
8.5
17.76
Illumina
ILMN
29.63
28.86
2.67
Invitrogen
IVGN
62.72
61.01
2.80
Luminex
LMNX
14.75
14.07
4.83
Millipore
MIL
72.01
70.1
2.72
Molecular Devices
MDCC
35.46
35.38
0.23
PerkinElmer
PKI
23.56
23.19
1.60
Qiagen
QGEN
16.39
16.05
2.12
Sequenom
SQNM
3.99
4.05
-1.48
Sigma-Aldrich
SIAL
41.38
40.01
3.42
Stratagene
STGN
8.5
8.4
1.19
Thermo
TMO
46.38
44.94
3.20
Third Wave
TWTI
5.2
5.13
1.36
Waters
WAT
57.21
55.78
2.56
BCW Index Average  
33.85
32.89
2.90
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.